HTS01037

Modify Date: 2024-01-11 08:04:24

HTS01037 Structure
HTS01037 structure
Common Name HTS01037
CAS Number 682741-29-3 Molecular Weight 337.371
Density 1.5±0.1 g/cm3 Boiling Point 621.2±55.0 °C at 760 mmHg
Molecular Formula C14H11NO5S2 Melting Point N/A
MSDS N/A Flash Point 329.5±31.5 °C

 Use of HTS01037


HTS01037 is an inhibitor of fatty acid binding; and a competitive antagonist of protein-protein interactions mediated by AFABP/aP2 with a Ki of 0.67 μM.

 Names

Name 4-[(2-methoxycarbonyl-5-thiophen-2-ylthiophen-3-yl)amino]-4-oxobut-2-enoic acid
Synonym More Synonyms

 HTS01037 Biological Activity

Description HTS01037 is an inhibitor of fatty acid binding; and a competitive antagonist of protein-protein interactions mediated by AFABP/aP2 with a Ki of 0.67 μM.
Related Catalog
Target

IC50: 0.67 μM (AFABP/aP2)[1]

In Vitro HTS01037 functions as a high affinity ligand of AFABP/aP2 with an apparent Ki of 0.67 μM. HTS01037 is somewhat selective for AFABP/aP2, but at higher concentrations is a pan-specific FABP inhibitor. HTS01037 inhibits lipolysis in 3T3-L1 adipocytes and reduces LPS-stimulated inflammation in cultured macrophages. HTS01037 acts as an antagonist of the protein-protein interaction between AFABP/aP2 and hormone sensitive lipase but does not activate PPARγ in macrophage or CV-1 cells[1]. Treatment of microglial cells with HTS01037 increases expression of Ucp2 and arginase in the presence or absence of palmitic acid. Moreover, cells exposed to HTS01037 exhibits attenuated expression of inducible nitric oxide synthase (iNOS) compared to palmitic acid alone indicating reduced NFκB signaling[2]. Treatment of macrophages with HTS01037results in a marked decrease in both basal and fatty acid-stimulated LTC4 secretion but no change in 5-HETE production or 5-lipoxygenase expression[3].
Kinase Assay To analyze the ligand (HTS01037) binding properties of the FABPs, the fluorescent ligand 1-anilinonapthalene 8-sulfonic acid (1,8-ANS) is utilized. 1,8 ANS is dissolved in absolute ethanol and diluted with 25 mM Tris-HCl (pH 7.4) to a final concentration of 5 μM (final EtOH concentration of 0.05%). Protein is titrated into 500 μL 1,8-ANS and the fluorescence enhancement is measured using a Perkin Elmer 650-10S fluorescence spectrophotometer with 4 nm excitation and emission slit widths. Quantitative analysis of ligand binding is evaluated using non-linear regression using PRISM software[1].
Cell Assay Cells are pretreated with HTS01037 or vehicle for 3 h and then challenged with or without palmitic acid for 1 h. Cells are then exposed to the ROS Deep Red Dye for 1 h in 5% CO2 at 37°C. Intracellular superoxide and hydroxyl radicals react with the deep red dye, producing a fluorescent signal which is measured using a spectrophotometer at 650Ex/675Em[2].
References

[1]. Hertzel AV, et al. Identification and characterization of a small molecule inhibitor of Fatty Acid binding proteins. J Med Chem. 2009 Oct 8;52(19):6024-31.

[2]. Duffy CM, et al. Identification of a fatty acid binding protein4-UCP2 axis regulating microglial mediated neuroinflammation. Mol Cell Neurosci. 2017 Apr;80:52-57.

[3]. Long EK, et al. Fatty acids induce leukotriene C4 synthesis in macrophages in a fatty acid binding protein-dependent manner. Biochim Biophys Acta. 2013 Jul;1831(7):1199-207.

 Chemical & Physical Properties

Density 1.5±0.1 g/cm3
Boiling Point 621.2±55.0 °C at 760 mmHg
Molecular Formula C14H11NO5S2
Molecular Weight 337.371
Flash Point 329.5±31.5 °C
Exact Mass 337.007874
PSA 149.18000
LogP 3.70
Vapour Pressure 0.0±1.9 mmHg at 25°C
Index of Refraction 1.672
Storage condition 2-8℃

 Synonyms

4-{[2-(methoxycarbonyl)-5-(2-thienyl)-3-thienyl]amino}-4-oxo-2-butenoic acid
(2E)-4-{[5-(Methoxycarbonyl)-2,2'-bithiophen-4-yl]amino}-4-oxo-2-butenoic acid
[2,2'-Bithiophene]-5-carboxylic acid, 4-[[(2E)-3-carboxy-1-oxo-2-propen-1-yl]amino]-, 5-methyl ester
HTS01037